Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Palliation
•
General Radiation Oncology
What is the role of RFA for symptomatic bone metastasis?
Is there any good data comparing RFA vs RT for painful bone metastasis?
Related Questions
If an anatomical defect forms due to rapid disease response from pelvic radiation for large gynecological tumors, is it safe to proceed with a further radiotherapy boost?
Is it safe to re-irradiate non-spine bone metastases with SBRT if they received previous SBRT?
Would you consider spine re-irradiation after Pluvicto?
With the addition of pembrolizumab following chemoradiation per KEYNOTE-A18, would you be less likely to treat the paraaortic chain prophylactically?
For epidural spinal cord compression in good-performance/prognosis patients who are otherwise inoperable, do you still aim for 30 Gy in 10 fractions, or are you fine with 20 Gy in 5 fractions?
Are there dosimetric scenarios where using a FFF beam would be beneficial in a non-modulated beam, like AP/PA or 3D conformal?
Do you constrain heterogeneity or hotspots when delivering spine SBRT for bone metastases?
What dose and fractionation would you use for a non-operable solitary fibrous tumor in the lumbar vertebra with definitive intent?
What screening tools or signs do you use to predict if a cancer patient is near end-of-life?
Can palliative radiation be used to treat recurrent malignant pleural effusion in NSCLC?